These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37870957)

  • 1. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
    Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
    Oh S; Song H; Freeman WM; Shin S; Janknecht R
    Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
    Li X; Moon G; Shin S; Zhang B; Janknecht R
    Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Kim TD; Shin S; Janknecht R
    Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
    Kim TD; Gu R; Janknecht R
    Int J Biochem Mol Biol; 2023; 14(6):101-115. PubMed ID: 38213775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
    Kim TD; Oh S; Lightfoot SA; Shin S; Wren JD; Janknecht R
    Int J Clin Exp Med; 2016; 9(6):10123-10134. PubMed ID: 28883898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites.
    Mallette FA; Mattiroli F; Cui G; Young LC; Hendzel MJ; Mer G; Sixma TK; Richard S
    EMBO J; 2012 Apr; 31(8):1865-78. PubMed ID: 22373579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering human JMJD2A tudor domains for an improved understanding of histone peptide recognition.
    Parkinson J; Hard R; Ainsworth R; Wang W
    Proteins; 2023 Jan; 91(1):32-46. PubMed ID: 35927178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
    An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D
    Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the histone demethylase KDM4A in cancer.
    Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
    Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice.
    Zhang QJ; Chen HZ; Wang L; Liu DP; Hill JA; Liu ZP
    J Clin Invest; 2011 Jun; 121(6):2447-56. PubMed ID: 21555854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
    Mallette FA; Richard S
    Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein.
    Van Rechem C; Black JC; Abbas T; Allen A; Rinehart CA; Yuan GC; Dutta A; Whetstine JR
    J Biol Chem; 2011 Sep; 286(35):30462-30470. PubMed ID: 21757720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
    Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
    Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
    Oh S; Shin S; Janknecht R
    Int J Clin Exp Pathol; 2021; 14(7):795-810. PubMed ID: 34367411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
    Kauffman EC; Robinson BD; Downes MJ; Powell LG; Lee MM; Scherr DS; Gudas LJ; Mongan NP
    Mol Carcinog; 2011 Dec; 50(12):931-44. PubMed ID: 21400613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A.
    Huang Y; Fang J; Bedford MT; Zhang Y; Xu RM
    Science; 2006 May; 312(5774):748-51. PubMed ID: 16601153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.